References
- Ader, R., Chatterjee, K., Ports, T., Brundage, B., Hiramatsu, B., Parmley, W. Immediate and sustained clinical improvement in chronic heart failure by an oral angiotensin converting enzyme inhibitor. Circulation 61:931–37, 1980.
- Smiseth, O.A., Mjøs, O.D. A reproducible and stable model of acute ischaemic left ventricular failure in dogs. Clin. Physiol. 2:225–39, 1982.
- Rudolph, A.M., Heymann, M.A. The circulation of the fetus in utero. Circ. Res. 21:163–84, 1967.
- Heymann, M.A., Payne, B.D., Hoffman, J.J.E., Rudolph, A.M. Blood flow measurements with radionuclide-labeled particles. Prog. Cardiovase. Dis. 20:55–79, 1977.
- Sweet, C.S., Lee Gaul, S., Reitz, P.M., Blain, E.H., Ribeiro, L.T. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Prepared manuscript.
- Zimmerman, B.G., Wong, P.C. Alterations in renal function produced by angiotensin converting enzyme inhibitors. In: Horovitz, Z.P., ed. Angiotensin converting enzyme inhibitors. Mechanisms of action and clinical implications. Baltimore-Munich: Urban & Schwarzenberg, 239–53, 1981.
- Faxon, D.P., Creager, M.A., Halperin, J.L. Regional circulatory response to converting enzyme inhibition in congestive heart failure. Br. J. Clin. Pharmac. 14:179–86, 1982.
- Freeman, R.H., Davis,J.O., Williams, G.M., DeForrest, J.M., Seymour, A.A., Rowe, B.P. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs. Circ. Res. 45:540–45, 1979.
- Mørkrid, L., Ofstad, J., Willassen, Y. Effect of steric restriction on the intracortical distribution of microspheres in the dog kidney. Ore. Res. 39:608–15, 1976.